ReviewDiscover oncology2025
The role of microRNAs on autophagy in cervical cancer: review.
Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circular RNAs in cervical cancer: from ceRNA networks to epitranscriptomic regulation, immune modulation, and metastatic reprogramming.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer (CC) is one of the top five most common cancers among women worldwide. A key cellular alteration in CC is the dysregulation of autophagy a vital process for maintaining cell homeostasis by degrading and recycling damaged components via lysosomes. Disrupted autophagy is associated with various stages of cancer development. This review explores the role of microRNAs (miRNAs) in regulating autophagy in cervical cancer. miRNAs influence autophagy by targeting specific genes or signaling pathways, acting either as promoters or suppressors of the process. Many microRNAs (miRNAs) involved in autophagy are dysregulated in cervical cancer. For example, miR-203, miR-34a, miR-23b, miR-100, and miR-145, known to activate autophagic proteins in various diseases, are found to be suppressed in cervical cancer. This highlights the significant potential of miRNAs in regulating autophagy, making them valuable as diagnostic and prognostic markers, as well as therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.